Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1978-7-24
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0003-3014
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1257-62
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:613876-Adolescent,
pubmed-meshheading:613876-Dihydralazine,
pubmed-meshheading:613876-Female,
pubmed-meshheading:613876-Humans,
pubmed-meshheading:613876-Hydralazine,
pubmed-meshheading:613876-Hypertension,
pubmed-meshheading:613876-Infant, Newborn,
pubmed-meshheading:613876-Infusions, Parenteral,
pubmed-meshheading:613876-Pre-Eclampsia,
pubmed-meshheading:613876-Pregnancy
|
pubmed:articleTitle |
[Continuous flow perfusion of dihydralazine during pregnancy toxemia. Favorable outcome].
|
pubmed:publicationType |
Journal Article,
Case Reports
|